Beta Drugs Limited Share Price and Company Fundamentals
Last traded: Last Thursday at 9:59 AM
Beta Drugs Limited develops, manufactures, and sells anti-cancer bulk drugs and finished dosages in India. The company offers cosmeceutical and oncology products. It also manufactures active pharmaceutical ingredients (API) and pharmaceutical formulation intermediates (PFI). The company exports its products. Beta Drugs Limited was founded in 1985 and is based in Panchkula, India.
Key Metrics
PE ratio
46.56
PB ratio
8.51
Dividend yield
-
Beta
-0.45
Market cap
₹20.83B
Enterprise value
₹22.40B
Company profile
| Industry / Sector | Drug Manufacturers - Specialty & Generic / Healthcare |
|---|---|
| Full time employees | 455 |
| Website | https://betadrugslimited.com |
| Mailing address | SCO-184 Sector-5 Panchkula 134114 India |
| Phone / Fax | 91 17 2258 5481 / |
Dividends
Dividend yield
-
Dividend amount
₹-
Payout ratio
0.00%
5Y Avg. yield
-%
Beta Drugs Limited paid ₹- dividend and the ex-dividend date was -.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.BETA dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.
Company Executives
As of Oct 2026, following are the company executives and directors listed on Beta Drugs Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Rahul Batra | Chairman & MD | 42 | |
| Mr. Varun Batra | Joint MD & Whole Time Director | 40 | |
| Mr. Nipun Arora | Chief Financial Officer | 41 | |
| Ms. Rajni Brar | Company Secretary & Compliance Officer | 39 | |
| Mr. Balwant Singh | Whole Time Director | 55 | |
| Mr. Ashutosh Shukla | VP of Sales & Marketing and Whole Time Director | 48 |
Profitability and management effectiveness
Profit margin
11.11%
Operating margin
18.34%
Return on assets
-
Return on equity
-
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of Beta Drugs Limited is 20.83B and its enterprise value is 22.40B. The enterprise value to revenue ratio of BETA is 5.46. The enterprise value to EBITDA ratio of BETA is 26.61.
Beta Drugs Limited (NSE:BETA) Frequently Asked Questions
1. What is Beta Drugs Limited's Stock Symbol?
Beta Drugs Limited trades on NSE under the ticker symbol "BETA".
2. What is Beta Drugs Limited's stock price today?
One share of BETA stock can currently be purchased for approximately ₹2055.
3. How can I contact Beta Drugs Limited?
Beta Drugs Limited's mailing address is SCO-184 Sector-5 Panchkula 134114 India. The company can be reached via phone at 91 17 2258 5481.
4. What is Beta Drugs Limited's official website?
The official website of Beta Drugs Limited is https://betadrugslimited.com.